European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 230-234 , March 2009

Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003

  • S.C. Mills

      Affiliations

    • Department of Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, 369, Fulham Road, London, UK
    • Corresponding Author InformationCorresponding author: 8, Quadrant Grove, London, NW5 4JN, UK. Tel.: +44 07939723118.
    • ,
  • M. Haq

      Affiliations

    • Thyroid Unit, Royal Marsden Hospital, Fulham Road, London, UK
    • ,
  • W.J.B. Smellie

      Affiliations

    • Department of Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, 369, Fulham Road, London, UK
    • ,
  • C. Harmer

      Affiliations

    • Thyroid Unit, Royal Marsden Hospital, Fulham Road, London, UK

,Accepted 9 June 2008.

References 

  1. Ewing J. Neoplastic diseases. 2nd ed.. Philadelphia, PA: Saunders; 1928;952–953
  2. Hundahl SA, Fleming ID, Fremgen A, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer. 1998;83:2638–2648
  3. Herrera MF, Hay ID, Wu PS, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 1992;16:669–674(discussion 675)
  4. Thompson NW, Dunn EL, Batsakis JG, et al. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139:555–560
  5. Heimann A, Moll U. Spinal metastasis of a thyroglobulin-rich Hurthle cell carcinoma detected by fine needle aspiration. Light and electron microscopic study of an unusual case. Acta Cytol. 1989;33:639–644
  6. Clark OH, Gerend PL. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms. J Clin Endocrinol Metab. 1985;61:773–778
  7. Masood S, Auguste LJ, Westerband A, et al. Differential oncogenic expression in thyroid follicular and Hurthle cell carcinomas. Am J Surg. 1993;166:366–368
  8. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004;11:279–287
  9. Sobin LH, Fleming ID. TNM classification of malignant tumors. 5th ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803–1804
  10. Haq M, Harmer C. Practical management of thyroid cancer. London: Springer; 2006;393–402
  11. Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer. 2003;97:1186–1194
  12. Stojadinovic A, Hoos A, Ghossein RA, et al. Hurthle cell carcinoma: a 60-year experience. Ann Surg Oncol. 2002;9:197–203
  13. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003;129:207–210
  14. Paunovic I, Krgovic K, Tatic S, et al. Surgery for thyroid Hurthle cell tumours–a single institution experience. Eur J Surg Oncol. 2006;32:458–461
  15. Sanz J, Cerpa F, Dominguez M, et al. [Hurthle cell carcinoma of the thyroid. A 41 years experience]. Rev Med Chil. 1999;127:821–826
  16. Pisanu A, Aste L, Piu S, et al. [Predictive factors for malignancy in Hurthle-cell thyroid neoplasia. Effect of surgical treatment]. Tumori. 2003;89:223–225
  17. Chen H, Nicol TL, Zeiger MA, et al. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy?. Ann Surg. 1998;227:542–546
  18. Wasvary H, Czako P, Poulik J, et al. Unilateral lobectomy for Hurthle cell adenoma. Am Surg. 1998;64:729–732(discussion 732–3)
  19. Janser JC, Pusel J, Rodier JF, et al. [Hurthle cell tumor of the thyroid gland. Analysis of a series of 33 cases]. J Chir (Paris). 1989;126:619–624
  20. Grossman RF, Clark OH. Hurthle cell carcinoma. Cancer Control. 1997;4:13–17
  21. Taylor H, Hyer S, Vini L, et al. Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer. Eur J Endocrinol. 2004;150:649–653
  22. Haq MHC. Practical management of thyroid cancer. London: Springer; 2006;171–192
  23. Foote RL, Brown PD, Garces YI, et al. Is there a role for radiation therapy in the management of Hurthle cell carcinoma?. Int J Radiat Oncol Biol Phys. 2003;56:1067–1072
  24. Lo CY, Chan WF, Lam KY, et al. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg. 2005;242:708–715
  25. Brooks JR, Starnes HF, Brooks DC, et al. Surgical therapy for thyroid carcinoma: a review of 1249 solitary thyroid nodules. Surgery. 1988;104:940–946
  26. Duntas L, Grab-Duntas BM. Risk and prognostic factors for differentiated thyroid cancer. Hell J Nucl Med. 2006;9:156–162

PII: S0748-7983(08)00203-5

doi: 10.1016/j.ejso.2008.06.007

European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 230-234 , March 2009

Article Tools

* Image Usage & Resolution